CervoMed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Net Income	-2.17	-5.8	-24.1	-16.14	-11.8	-26.62	-2.62	-18.04	-6.72	-14.35	Upgrade
Depreciation & Amortization	0	0	0.09	0.1	0.1	0.11	0.07	0.03	0.01	0.57	Upgrade
Share-Based Compensation	0.41	0.46	0.9	0.74	0.52	1.22	1.24	1.39	0.59	1.65	Upgrade
Other Operating Activities	-5.69	2.77	8.6	-0.21	1.33	6.27	-12.28	5.85	0.93	3.1	Upgrade
Operating Cash Flow	-7.45	-2.57	-14.5	-13.55	-9.86	-10.77	-12.33	-10.77	-5.19	-9.03	Upgrade
Capital Expenditures	0	0	0	0	0	0	-0.45	-0	-0.04	-0.05	Upgrade
Acquisitions	0	0	0	0	0	0	0	8.5	0	0	Upgrade
Change in Investments	0	0	0	0	0	0	0	0	2.5	0	Upgrade
Investing Cash Flow	0	0	0	0	0	0	-0.45	8.5	2.46	-0.05	Upgrade
Share Issuance / Repurchase	12.7	0	33.3	18.87	16.21	10.85	0	0	0	31.85	Upgrade
Debt Issued / Paid	0	0	0	0	0	-0.55	-1.88	1.88	2.4	-1.14	Upgrade
Other Financing Activities	-1.55	-	-	-0.98	-0.16	-0.43	22	-0.05	-0.02	-	Upgrade
Financing Cash Flow	11.15	0	33.3	17.89	16.04	9.87	20.12	1.83	2.39	30.71	Upgrade
Net Cash Flow	3.7	-2.57	18.8	4.34	6.19	-0.91	7.34	-0.44	-0.34	21.63	Upgrade
Free Cash Flow	-7.45	-2.57	-14.5	-13.55	-9.86	-10.77	-12.78	-10.77	-5.23	-9.08	Upgrade
Free Cash Flow Margin	-104.27%	-	-	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-2.80	-4.96	-11.17	-18.88	-110.25	-249.19	-1158.22	-1184.13	-2243.87	-7144.44	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).